Ian Graham is Professor of Cardiovascular Medicine in Trinity College, Dublin, and Professor Emeritus of Preventive Cardiology at the Royal College of Surgeons in Ireland. He was recently a Board Member and Secretary-Treasurer of the European Society of Cardiology (ESC) and Chair of the Adelaide Health Foundation. He has recently served on the ESC’s Nominating committee and Chaired its Statutes and Governance revision Task Force He was a member of the 6th Joint European Societies Task Force on the Prevention of Cardiovascular Disease in clinical practice and of its Prevention Implementation Committee, having Chaired the 4th Task Force. He was co-Chair of the 2016 European Guidelines on the management of dyslipidaemias, an author of the 2019 Guidelines and reviewer of the 2021 Prevention Guidelines. Prof Graham attended Downside and Whitgift Schools in the U.K., studied medicine at Trinity College in Dublin and trained in Dublin and Cambridge before becoming Head of Cardiology at Tallaght University Hospital in Dublin and Vice-Chair of its Board of management. He was Director of Research at St Vincent’s Hospital in Dublin and at the Irish Heart Foundation. He is past President of the Irish Heart Foundation, the Dublin University Biological Association and the Irish Hyperlipidaemia Association. He founded the Irish National Cardiac Surgery register. He holds Fellowships with the following bodies: Trinity College Dublin, the European Society of Cardiology, the Royal College of Physicians in Ireland, the Royal Academy of Medicine in Ireland, the Irish Cardiac Society and the National Institute of Preventive Cardiology. He is a life member of the Royal Society of Medicine in London. He is a recipient of the Stokes Medal of the Irish Cardiac Society, and the Sir Thomas and Lady Dixon Medal from the Royal Victoria Hospital in Belfast. He held a Medical Research Council Fellowship, a EU travelling Fellowship at Erasmus University in Rotterdam and an ISFC Cardiovascular Epidemiology Fellowship. Prof Graham is Project leader of the EU Concerted Action Project SCORE (Systematic COronary Risk Evaluation) and of its electronic derivative, HeartScore. He is a member of the EuroAspire cardiovascular risk factor audit, and Project Leader of a simplified international audit of cardiovascular risk factor control, SURF (Survey of Risk Factors). On behalf of the Board of the ESC, he established a Patient engagement initiative. He is Co-Chair of the ESC’s Cardiovascular Risk Collaboration (CRC) an international consortium that has published on new aspects of cardiovascular risk estimation such as SCORE2. He is an Editorial Board Member for Atherosclerosis, and an Associate Editor of the American Journal of Preventive Cardiology Research interests include the natural history of coronary heart disease, cardiovascular risk estimation, blood lipids, health policy and planning and the evaluation of therapies. He has written extensively in these areas.